Physician

Syed Nasir, MD

According to 2025 Medicare claims, Syed Nasir, MD (NPI: 1669587093) practices internal medicine in the Kiryas Joel-Poughkeepsie-Newburgh, NY market, with the plurality of this provider's patient population coming from Orange, NY. Nasir uses personal NPI as billing NPI and primary practice location at 10940-2650.

Nasir's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,492 traditional Medicare patients, billed 9,790 HCPCS/CPT codes, and received $846,935 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 5,952 prescription claims across 610 beneficiaries totaling $501,312 in drug costs, led by Teriflunomide (Teriflunomide). 2022 DME data shows 24 claims. Open Payments data shows 23 records totaling $495. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $445,303 to $846,935. In contrast, Part D prescription costs have fallen sharply in recent years, from $1,663,395 to $501,312. For DME billing, this smaller-volume category fell sharply in recent years, from $1,195 to $1,871.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,077	5,359	$445,303
2016	1,206	5,627	$468,968
2017	1,417	6,683	$577,750
2018	1,726	7,804	$670,073
2019	1,629	6,656	$646,149
2020	1,420	7,108	$666,768
2021	1,203	7,026	$721,555
2022	1,222	7,921	$788,498
2023	1,354	7,564	$763,519
2024	1,492	9,790	$846,935

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	688	7,370	$1,663,395
2016	646	6,687	$1,607,749
2017	650	6,812	$1,452,928
2018	720	7,140	$1,257,767
2019	708	7,174	$1,195,411
2020	651	6,600	$1,065,015
2021	642	6,524	$903,504
2022	613	6,179	$646,227
2023	601	6,151	$723,631
2024	610	5,952	$501,312

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	14	$361
2017	N/R	48	$1,315
2018	N/R	11	$105
2019	N/R	37	$1,110
2020	N/R	N/R	N/R
2021	N/R	56	$948
2022	N/R	24	$468
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	756	826	$139
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	850	2,825	$97
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	478	1,134	$96
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	501	1,464	$64
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	554	1,545	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Teriflunomide	Teriflunomide	39	1,170	$162,718
Eliquis	Apixaban	45	2,190	$41,868
Rivastigmine	Rivastigmine	160	7,200	$27,111
Aspirin-Dipyridamole Er	Aspirin/Dipyridamole	116	6,660	$19,941
Brilinta	Ticagrelor	37	1,324	$19,932

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	23	$495	Teva Pharmaceuticals USA, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Syed Nasir, MD?

Tedicare shows public-source Medicare data for Syed Nasir, MD (NPI 1669587093), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Syed Nasir, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Syed Nasir, MD?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does Syed Nasir, MD have Open Payments data?

Syed Nasir, MD has 23 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.